Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2010 (2010), Article ID 357591, 6 pages
http://dx.doi.org/10.1155/2010/357591
Review Article

Mycobacterium bovis Bacillus Calmette-Guérin-Induced Macrophage Cytotoxicity against Bladder Cancer Cells

Department of Urology, University of Iowa, 375 Newton Road, 3202 MERF, Iowa City, IA 52242, USA

Received 15 June 2010; Accepted 16 August 2010

Academic Editor: Bernhard Fleischer

Copyright © 2010 Yi Luo and Matthew J. Knudson. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [23 citations]

The following is the list of published articles that have cited the current article.

  • Hiroshi Kitamura, and Taiji Tsukamoto, “Immunotherapy for urothelial carcinoma: Current status and perspectives,” Cancers, vol. 3, no. 3, pp. 3055–3072, 2011. View at Publisher · View at Google Scholar
  • Qingbo Li, “Phagosome proteomics: A powerful tool to assess bacteria-mediated immunomodulation,” Bioengineered Bugs, vol. 2, no. 4, pp. 194–198, 2011. View at Publisher · View at Google Scholar
  • Hao Yu, “Bacteria-mediated disease therapy,” Applied Microbiology and Biotechnology, vol. 92, no. 6, pp. 1107–1113, 2011. View at Publisher · View at Google Scholar
  • Diana M Rommelfanger, Marta C Grau, Rosa M Diaz, Elizabeth Ilett, Luis Alvarez-Vallina, Jill M Thompson, Timothy J Kottke, Alan Melcher, and Richard G Vile, “The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice,” Molecular Therapy, vol. 21, no. 2, pp. 348–357, 2012. View at Publisher · View at Google Scholar
  • Goshi Kato, Hidehiro Kondo, Takashi Aoki, and Ikuo Hirono, “Mycobacterium bovis BCG vaccine induces non-specific immune responses in Japanese flounder against Nocardia seriolae,” Fish & Shellfish Immunology, vol. 33, no. 2, pp. 243–250, 2012. View at Publisher · View at Google Scholar
  • Krzysztof Bryniarski, and Katarzyna Nazimek, “The biological activity of macrophages in health and disease,” Postepy Higieny I Medycyny Doswiadczalnej, vol. 66, pp. 507–520, 2012. View at Publisher · View at Google Scholar
  • Xing-Qing Pan, “The mechanism of the anticancer function of M1 macrophages and their use in the clinic,” Chinese Journal of Cancer, vol. 31, no. 12, pp. 557–563, 2012. View at Publisher · View at Google Scholar
  • Brant A. Inman, “Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance,” European Urology, vol. 64, no. 1, pp. 171–172, 2013. View at Publisher · View at Google Scholar
  • Adele Mount, Sandra Koernig, Anabel Silva, Debbie Drane, Eugene Maraskovsky, and Adriana Baz Morelli, “Combination of adjuvants: the future of vaccine design,” Expert Review of Vaccines, vol. 12, no. 7, pp. 733–746, 2013. View at Publisher · View at Google Scholar
  • Michele De Palma, and Claire E. Lewis, “Macrophage Regulation of Tumor Responses to Anticancer Therapies,” Cancer Cell, vol. 23, no. 3, pp. 277–286, 2013. View at Publisher · View at Google Scholar
  • Kristen B Long, and Gregory L Beatty, “Harnessing the antitumor potential of macrophages for cancer immunotherapy,” OncoImmunology, vol. 2, no. 12, pp. e26860, 2013. View at Publisher · View at Google Scholar
  • Koji Kawai, Jun Miyazaki, Akira Joraku, Hiroyuki Nishiyama, and Hideyuki Akaza, “Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine,” Cancer Science, vol. 104, no. 1, pp. 22–27, 2013. View at Publisher · View at Google Scholar
  • David B Thompson, Larry E Siref, Michael P Feloney, Ralph J Hauke, and Devendra K Agrawal, “Immunological basis in the pathogenesis and treatment of bladder cancer,” Expert Review of Clinical Immunology, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • R. Braster, M. Bögels, R.H.J. Beelen, and M. van Egmond, “The delicate balance of macrophages in colorectal cancer; their role in tumour development and therapeutic potential,” Immunobiology, 2015. View at Publisher · View at Google Scholar
  • Hilda Chávez-Navarro, Daniel Dimitri Hernández-Cueto, Ariel Vilchis-Estrada, David César Bermúdez-Pulido, Gabriela Antonio-Andrés, and Rosendo Luria-Pérez, “Salmonella enterica: un aliado en la terapia contra el cáncer,” Boletín Médico del Hospital Infantil de México, 2015. View at Publisher · View at Google Scholar
  • K. R. Begnini, J. H. Buss, T. Collares, and F. K. Seixas, “Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer,” Applied Microbiology and Biotechnology, 2015. View at Publisher · View at Google Scholar
  • Zhiqun Shang, Yanjun Li, Minghao Zhang, Jing Tian, Ruifa Han, Chih-Rong Shyr, Edward Messing, Shuyuan Yeh, Yuanjie Niu, and Chawnshang Chang, “Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Pr,” Molecular Cancer Therapeutics, vol. 14, no. 11, pp. 2586–2594, 2015. View at Publisher · View at Google Scholar
  • Cristina Belgiovine, Maurizio D’Incalci, Paola Allavena, and Roberta Frapolli, “Tumor-associated macrophages and anti-tumor therapies: complex links,” Cellular and Molecular Life Sciences, 2016. View at Publisher · View at Google Scholar
  • L. V. Sakhno, E. Ya. Shevela, M. A. Tikhonova, A. A. Ostanin, and E. R. Chernykh, “The Phenotypic and Functional Features of Human M2 Macrophages Generated Under Low Serum Conditions,” Scandinavian Journal of Immunology, vol. 83, no. 2, pp. 151–159, 2016. View at Publisher · View at Google Scholar
  • Wen Yue, Mark N. Stein, Xiang-Lin Tan, Ran Cui, Edmund C. Lattime, and Qing Xu, “Targeting tumor-associated macrophages to combat pancreatic cancer,” Oncotarget, vol. 7, no. 31, pp. 50735–50754, 2016. View at Publisher · View at Google Scholar
  • Sean Sweeney, Andrea Adamcakova-Dodd, Peter S. Thorne, and Jose G. Assouline, “Biocompatibility of multi-imaging engineered mesoporous silica nanoparticles: In vitro and adult and fetal in vivo studies,” Journal of Biomedical Nanotechnology, vol. 13, no. 5, pp. 544–558, 2017. View at Publisher · View at Google Scholar
  • Samer Bazzi, Emale El-Darzi, Tina McDowell, Helmout Modjtahedi, Satvinder Mudan, Marcel Achkar, Charles Akle, Humam Kadara, and Georges M. Bahr, “Defining Genome-Wide Expression and Phenotypic Contextual Cues in Macrophages Generated by Granulocyte/Macrophage Colony-Stimulating Factor, Macrophage Colony-Stimulating Factor, and Heat-Killed Mycobacteria,” Frontiers in Immunology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Liang Piao, Zhao Canguo, Lu Wenjie, Cheng Xiaoli, Shi Wenli, and Lu Li, “Lipopolysaccharides-stimulated macrophage products enhance Withaferin A-induced apoptosis via activation of caspases and inhibition of NF-κB pathway in human cancer cells,” Molecular Immunology, vol. 81, pp. 92–101, 2017. View at Publisher · View at Google Scholar